| Description |
1 online resource (306 pages) |
| Contents |
New Arrhythmia Technologies; Contents; List of Contributors; Preface; Part I: Advances in antiarrhythmic pharmacologic therapy; 1 New antiarrhythmic pharmacologic therapies and regulatory issues in antiarrhythmic drug development; 2 New frontiers in antithrombotic therapy for atrial fibrillation; Part II: Future of antiarrhythmic therapy; 3 Principles of pharmacogenomics: Focus on arrhythmias; 4 The cardiac sodium-channel carboxy terminus: predicted and detected structure provide a novel target for antiarrhythmic drugs development |
|
5 Embryonic stem-cell-derived cardiomyocytes as a model for arrhythmia6 Gene and cell therapy for sinus and AV nodal dysfunction; 7 Gene therapy for cardiac tachyarrhythmias; Part III: Monitoring, noninvasive mapping, risk assessment, and external defibrillation; 8 New developments in noninvasive rhythm monitoring, implantable hemodynamic monitoring, functional status monitoring and noninvasive mapping; 9 Techniques of prediction of arrhythmia occurrence and stratificat |
| Summary |
New Arrhythmia Technologies provides a complete discussion of recent, emerging, and future arrhythmia technologies. This forward-thinking book details successful trials and investigates areas of research that have not yet reached the trial phase. The elite panel of authors have explored fresh information on:.:.; advances in antiarrhythmic pharmacologis therapy.; advances in monitoring, risk assessment, and noninvasive mapping.; advances in pacing therapy.; advances in implantable defibrillators.; advances in catheter and surgical ablation.; advances in antiarrhythmic biological therapy.; visio |
| Notes |
Print version record |
| Subject |
Arrhythmia -- Treatment -- Technological innovations
|
| Form |
Electronic book
|
| Author |
Naccarelli, Gerald V
|
|
Rosen, Michael R
|
| ISBN |
9780470994207 |
|
0470994207 |
|
